| Annual · values | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | — | — | — | -2072.05% | -3542.53% | -1197.07% | -912.04% | -2612.53% | -3228.82% | -1555.41% | -494.58% | -523.71% |
| EBITDA Margin | — | — | — | -2030.10% | -3500.48% | -1191.01% | -907.99% | -2599.16% | -3204.98% | -1547.15% | -490.24% | -518.81% |
| Net Margin | — | — | — | -2094.89% | -3540.90% | -1196.58% | -980.33% | -2697.75% | -3795.86% | -1855.81% | -549.57% | -891.53% |
| Current Ratio | 3.85 | 3.13 | 3.40 | 10.03 | 9.95 | 7.53 | 9.40 | 2.21 | 15.13 | 2.61 | 4.57 | 2.10 |
| Quick Ratio | 3.85 | 3.13 | 3.40 | 10.03 | 9.95 | 7.53 | 9.40 | 2.21 | 15.13 | 2.61 | 4.57 | 2.10 |
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — |
| ROE | -146.36% | -261.31% | -211.71% | -79.86% | -61.30% | -84.86% | -68.70% | -269.44% | -94.14% | -1222.03% | -324.31% | -1043.50% |
| ROA | -112.92% | -181.91% | -148.05% | -68.71% | -53.64% | -73.92% | -61.36% | -150.25% | -77.25% | -421.47% | -190.57% | -492.34% |
| Asset Turnover | — | — | 0.00 | 0.03 | 0.02 | 0.06 | 0.06 | 0.06 | 0.02 | 0.23 | 0.35 | 0.55 |
| Book Value / Share | 7.25 | 3.28 | 2.29 | 0.73 | 1.15 | 0.77 | 2.72 | 0.13 | 0.49 | 0.08 | 0.20 | 0.12 |
Aethlon Medical Inc. is a medical technology company focused on developing immunotherapeutic products for cancer and infectious disease. Its primary platform, the Aethlon Hemopurifier, is designed to reduce cancer-promoting exosomes and circulating viruses through extracorporeal blood filtration. The company’s work centers on clinical-stage solutions that address life- and organ-threatening conditions, with applications that intersect oncology, virology, and critical care medicine. Aethlon Medical serves the broader healthcare market by advancing device-based technologies intended for diagnostic and therapeutic use in severe diseases. Headquartered in San Diego, California, Aethlon Medical Inc. operates as a specialized developer of highly targeted medical treatments within the biotechnology and medical device sectors.